MetLife Investment Management, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1529735
Whippany, NJ
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,266,595
-$3,942,211 QoQ
Shares Held
22,880
-2.9% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#247
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. REGN ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,266,595 | 22,880 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $18,208,806 | 23,567 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $18,659,185 | 24,174 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $14,235,551 | 25,318 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,896,750 | 26,470 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $17,566,268 | 27,697 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $20,116,199 | 28,240 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $29,400,029 | 27,967 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $30,138,285 | 28,675 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $24,030,487 | 24,967 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $23,016,467 | 26,206 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $21,919,539 | 26,635 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $19,828,829 | 27,596 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $23,229,432 | 28,271 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $20,563,186 | 28,501 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $19,984,118 | 29,010 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $17,516,955 | 29,633 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $20,559,389 | 29,437 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $14,751,675 | 23,359 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $14,366,973 | 23,740 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $13,557,441 | 24,273 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $11,871,082 | 25,090 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $12,302,879 | 25,466 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $14,838,088 | 26,507 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $16,452,510 | 26,381 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $10,054,379 | 20,591 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||